Page last updated: 2024-10-30

labetalol and Fetal Death

labetalol has been researched along with Fetal Death in 7 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Fetal Death: Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH.

Research Excerpts

ExcerptRelevanceReference
"Labetalol was compared with methyldopa in a randomized controlled trial involving 176 pregnant women with mild to moderate hypertension."9.06Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. ( Breart, G; Maillard, F; Papiernik, E; Plouin, PF; Relier, JP, 1988)
"Hypotension is more common after maternal labetalol exposure, regardless of the dosage and route of administration."5.38Neonatal side effects of maternal labetalol treatment in severe preeclampsia. ( Heida, KY; Hulzebos, CV; Van Veen, TR; Zeeman, GG, 2012)
"Labetalol was compared with methyldopa in a randomized controlled trial involving 176 pregnant women with mild to moderate hypertension."5.06Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. ( Breart, G; Maillard, F; Papiernik, E; Plouin, PF; Relier, JP, 1988)
"Hypotension is more common after maternal labetalol exposure, regardless of the dosage and route of administration."1.38Neonatal side effects of maternal labetalol treatment in severe preeclampsia. ( Heida, KY; Hulzebos, CV; Van Veen, TR; Zeeman, GG, 2012)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's2 (28.57)18.2507
2000's1 (14.29)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdel-Hady, el-S1
Fawzy, M1
El-Negeri, M1
Nezar, M1
Ragab, A1
Helal, AS1
Heida, KY1
Zeeman, GG1
Van Veen, TR1
Hulzebos, CV1
Hurst, JA1
Houlston, RS1
Roberts, A1
Gould, SJ1
Tingey, WG1
Hussein, M1
Mooij, JM1
Roujouleh, H1
Olsen, KS1
Beier-Holgersen, R1
Chimura, T1
Plouin, PF1
Breart, G1
Maillard, F1
Papiernik, E1
Relier, JP1

Trials

1 trial available for labetalol and Fetal Death

ArticleYear
Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial.
    British journal of obstetrics and gynaecology, 1988, Volume: 95, Issue:9

    Topics: Adult; Clinical Trials as Topic; Female; Fetal Death; Fetus; Hemodynamics; Humans; Hypertension; Inf

1988

Other Studies

6 other studies available for labetalol and Fetal Death

ArticleYear
Is expectant management of early-onset severe preeclampsia worthwhile in low-resource settings?
    Archives of gynecology and obstetrics, 2010, Volume: 282, Issue:1

    Topics: Adolescent; Adult; Antihypertensive Agents; Egypt; Female; Fetal Death; Fetal Monitoring; Gestationa

2010
Neonatal side effects of maternal labetalol treatment in severe preeclampsia.
    Early human development, 2012, Volume: 88, Issue:7

    Topics: Adult; Antihypertensive Agents; Case-Control Studies; Female; Fetal Death; Humans; Infant Mortality;

2012
Transverse limb deficiency, facial clefting and hypoxic renal damage: an association with treatment of maternal hypertension?
    Clinical dysmorphology, 1995, Volume: 4, Issue:4

    Topics: Abnormalities, Drug-Induced; Adult; Child, Preschool; Facial Bones; Female; Fetal Death; Fetus; Huma

1995
Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
    Kidney & blood pressure research, 2001, Volume: 24, Issue:2

    Topics: Antihypertensive Agents; Apgar Score; Cesarean Section; Comorbidity; Disease Susceptibility; Female;

2001
Fetal death following labetalol administration in pre-eclampsia.
    Acta obstetricia et gynecologica Scandinavica, 1992, Volume: 71, Issue:2

    Topics: Adult; Cesarean Section; Female; Fetal Death; Humans; Labetalol; Pre-Eclampsia; Pregnancy; Premedica

1992
[Effects of beta-adrenoceptor blockade on parturition and fetal cardiovascular and metabolic system].
    Nihon Sanka Fujinka Gakkai zasshi, 1985, Volume: 37, Issue:5

    Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Blood Glucose; Ethanolamines; Female; Fetal Death;

1985